Genetic disorders of calcium and phosphorus metabolism

Critical Reviews in Clinical Laboratory Sciences

Volumn 37, Issue 3, 2000, Pages 217-260

  Root, Allen W ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

Author keywords

Bone; Calcium; Chondrodystrophy; Hypercalcemia; Hypocalcemia; Hypophosphatemia; Parathyroid hormone; Phosphorus; Rickets; Vitamin D

Indexed keywords

CALCIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHORUS; VITAMIN D; VITAMIN D RECEPTOR;

BONE DISEASE; BONE METABOLISM; CALCIUM METABOLISM; CHONDRODYSPLASIA; DIGEORGE SYNDROME; ELECTROLYTE DISTURBANCE; GENE MUTATION; HUMAN; HYPOCALCEMIA; METABOLIC DISORDER; MULTIPLE ENDOCRINE NEOPLASIA; PHOSPHATE METABOLISM; PRIORITY JOURNAL; REVIEW; RICKETS; WILLIAMS BEUREN SYNDROME;

EID: 0033918895     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408360091174213     Document Type: Review

References (71)

1. 1. Root AW. Recent advances in the genetics of disorders of calcium homeostasis. Adv Pediatr 1996; 43: 77-125.
2. 2. Cole DEC, Peltekova VD, Rubin LA, et al. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 1999; 353: 112-115.
3. 3. Williams PD, Puddey IB, Martin NG, et al. Plasma cytosolic free calcium concentration, total plasma calcium concentration and blood pressure in human twins: a genetic analysis. Clin Sci 1992; 82: 493-504.
4. 4. Bushinsky DA, Monk RD. Calcium. Lancet 1998; 352: 306-311.
5. 5. Breslau NA. Calcium, magnesium, and phosphorus: Intestinal absorption. In: Favus M, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd ed, Lippincott-Raven, Philadelphia, 1996, pp. 41-49.
6. 6. Breslau NA. Calcium, magnesium, and phosphorus: Renal handling and urinary excretion. In: Favus M, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd ed, Lippincott-Raven, Philadelphia, 1996, pp. 49-57.
7. 7. Chattopadhay N, Mithal A, Brown EM. The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. Endocrine Rev 1996; 17: 289-307.
8. 2+-sensing receptor: molecular biology and clinical importance. Curr Opin Pediatr 1998; 10: 435-440.
9. 2+ receptor from brain to gut: common stimulus, diverse actions. Trends Endocrinol Metab 1998; 9: 354-359.
10. 10. Pearce GHS, Brown EM. The genetic basis of endocrine disease: disorders of calcium ion sensing. J Clin Endocrinol Metab 1996; 81: 2030-2035.
11. 11. Pearce GHS, Trump D, Wooding C, et al. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 1995; 96: 2683-2692.
12. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 1598-1606.
13. 13. McPherson JD, Krane MC, Wagner-McPherson CB, et al. High-resolution mapping of the renal sodium-phosphate cotransporter gene (NPT2) confirms its localization to human chromosome 5q35. Pediatr Res 1997; 41: 632-634.
14. 14. Carpenter TO. New perspectives on the biology and treatment of X-linked hypophosphatemic rickets. Pediatr Clin NA 1997; 44: 443-446.
15. 15. Dixon PH, Christie PT, Wooding C, et al. Mutational analysis of the PHEX gene in X-linked hypophosphatemia. J Clin Endocrinol Metab 1998; 83: 3615-3623.
16. 16. Econs MJ, Friedman NE, Rowe PSN, et al. A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: Evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 1998; 83: 3459-3462.
17. 17. Francis F, Strom TM, Hennig S, et al. Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. Genome Res 1997; 7: 573-685.
18. 18. Rowe PSN, Oudet CL Francis F, Distribution of mutations in the PEX gene in families with X-linked hypophosphatemic rickets (HYP). Hum Molec Genet 1997; 6: 539-549.
19. 19. Ivker R, Resnick SD Skidmore RA. Hypophosphatemic vitamin D-resistant rickets, precocious puberty, and the epidermal nevus syndrome. Arch Dermatol 1997; 133: 1557-1561.
20. 20. Nelson AE, Robinson BG Mason RS. Oncogenic osteomalacia: is there a new phosphate regulating hormone? Clin Endocrinol 1997; 47: 635-642.
21. 21. Rowe PSN. The PEX gene: its role in X-linked rickets, osteomalacia, and bone mineral metabolism. Exp Nephrol 1997; 5: 355-363.
22. 22. Lloyd SE, Pearce GHS, Fisher SE, et al. A common molecular basis for three inherited kidney stone diseases. Nature 1996; 370: 445-449.
23. 23. Silver J, Moallem E, Kilav A, et al. Regulation of the parathyroid hormone gene by calcium, phosphate and 1,25-dihydroxyvitamin D. Nephrol Dialysis Transplant 1998; 13(Suppl 1): 40-44.
24. 24. Arnold A, Horst SA, Gardella TJ, et al. Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest 1990; 86: 1084-1087.
25. 25. Karaplis AC, Lim SK, Baba H, et al. Inefficient membrane targeting, translocation, and proteolytic processing by signal peptidase of a mutant preproparathyroid hormone protein. J Biol Chem 1995; 270: 1629-1635.
26. 26. Parkinson DB, Thakker RV. A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1992; 1: 149-152.
27. 27. Yamamoto T, Yoshimasa Y, Koshiyama H, et al. Lack of mutations of preproparathyroid hormone gene in three kindreds with familial isolated hypoparathyroidism. Endocrine J 1997; 44: 175-181.
28. 28. Fujikawa M, Okamura K, Sato K, et al. Familial isolated hyperparathyroidism due to multiple adenomas associated with ossifying jaw fibroma and multiple uterine adenomyomatous polyps. Eur J Endocrinol 1998; 138: 557-561.
29. 29. Teh BT, Farnebo F, Twigg S, et al. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab 1998; 83: 2114-2120.
30. 30. Thakker RV. Editorial: Multiple endocrine neoplasia - syndromes of the twentieth century. J Clin Endocrinol Metab 1998; 83: 2617-2620.
31. 31. Marx SJ, Agarwal SK, Kester MB et al. Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1). J Intern Med 1998; 243: 447-453.
32. 32. The BT, Kytola S, Farnebo F, et al. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab 1998; 83: 2621-2626.
33. 33. Bassett JHD, Forbes SA, Pannett AAJ, et al. Characterization of mutations in patients with multiple endocrine neoplasia type I. Am J Hum Genet 1998; 62: 232-244.
34. 34. Takahashi M, Asai N, Iwashita T, et al. Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations. J Intern Med 1998; 243: 509-511.
35. 35. Santoro M, Melillo RM, Carlomagno F, et al. Molecular biology of the MEN2 gene. J Intern Med 1998; 243: 505-508.
36. 36. Doray B, Salomon R, Amiel J, et al. Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschprung disease. Hum Mol Genet 1998; 7: 1449-1452.
37. 37. Eng C, Mulligan LM. Mutations of the RET protooncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschprung disease. Hum Mutat 1997; 9: 97-109.
38. 38. Vortkamp A, Lee K, Lanske B, et al. Regulation of the rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996; 273: 613-622.
39. 39. Nissenson RA. Editorial: Parathyroid hormone (PTH)/PTHrP receptor mutations in human chondrodysplasia. Endocrinology 1998; 139: 4753-4755.
40. 40. Findlay DM, Martin TJ. Receptors of calciotropic hormones. Horm Metab Res 1997; 29: 128-134.
41. 41. Usdin TB, Gruber C Bonner TI. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 1996; 270: 15455-15458.
42. 42. Schipani E, Langman CB, Parfitt AM, et al. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med 1996; 335: 708-714.
43. 43. Minigawa M, Arakawa K, Takeuchi S, et al. Jansen-type metaphyseal chondrodysplasia: analysis of PTH/PTH related protein receptor messenger RNA by the reverse transcriptase-polymerase chain method. Endocrine J 1997; 44: 493-499.
44. 44. Jobert AS, Zhang P, Couvineau A et al. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 1998; 102: 34-40.
45. 45. Karaplis AC, He B, Nguyen MT, et al. Inactivating mutation in the human parathyroid hormone receptor type I gene in Blomstrand chondrodysplasia. Endocrinology 1998; 139: 5255-5258.
46. 46. Zhang P, Jobert AS, Couvineau A, et al. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J Clin Endocrinol Metab 1998; 83: 3365-3368.
47. sα gene mutation. Am J Med Genet 1998; 77: 261-267.
48. 48. Juppner H, Schipani E, Bastepe M, et al. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Nat Acad Sci USA 1998; 95: 11798-11801.
49. s. J Pediatr 1993; 123: 509-518.
50. 50. Mimouni FB, Root AW. Disorders of calcium metabolism in the newborn. In: Sperling MA, ed. Pediatric endocrinology, pp. 95-115. WB Saunders Co, Philadelphia, 1996.
51. 51. Casella SJ, Reiner BJ, Chen TC, et al. A possible genetic defect in 25-hydroxylation as a cause of rickets. J Pediatr 1994; 124: 929-932.
52. 52. Fu GK, Lin D, Zhang MYH, et al. Cloning of human 25-hydroxyvitamin D-1α-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 1997; 11: 1961-1970.
53. 3 1α-hydroxylase. Biochem Biophys Res Commun 1997; 239: 527-533.
54. 54. Wang JT, Lin C-J, Burridge SM, et al. Genetics of vitamin D 1α-hydroxylase deficiency in 17 families. Am J Hum Genet 1998; 63: 1694-1702.
55. 3 1α-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 1998; 338: 653-661.
56. 56. Miyamoto K, Kesterson RA, Yamamoto H, et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 1997; 11: 1165-1179.
57. 57. Carling T, Rastad J, Akerstrom G, et al. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 1998; 83: 2255-2259.
58. 58. Ferrari S, Bonjour J-P Rizolli R. The vitamin D receptor gene and calcium metabolism. Trends Endocrinol Metab 1998; 9: 259-265.
59. 3. Trends Endocrinol Metab 1998; 9: 419-427.
60. 60. Watson CS, Gametchu B. Membrane-initiated steroid actions and the proteins that mediate them. Proc Soc Exp Biol Med 1999; 220: 9-19.
61. 61. Haussler MR, Haussier CA, Jurutka PW, et al. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 1997; 154: S57-S73.
62. 62. Adachi M, Tachibana K, Masuno M, et al. Clinical characteristics of children with hypoparathyroidism due to 22q11.2 microdeletion. Eur J Pediatr 1998; 157: 33-38.
63. 63. Keating MT. On the trail of genetic culprits in Williams syndrome. Cardiovasc Res 1997; 36: 134-137.
64. 64. Brook CGD, de Vries BBA. Skeletal dysplasias. Arch Dis Child 1998; 79: 285-289.
65. 65. Horton WA. Molecular genetics of human chondrodysplasias. Growth Genet Horm 1997; 13: 49-55.
66. 66. Young ID. Achondroplasia: a case of neglect? Lancet 1998; 352: 1950-1951.
67. 67. Horton WA. Fibroblast growth factor receptor 3 and the human chondrodysplasias. Curr Opin Pediatr 1997; 9: 437-442.
68. 68. Horton WA. Molecular genetic basis of the human chondrodysplasias. Endocrinol Metab Clin NA 1996; 25: 683-697.
69. 69. Haque MF, King LM, Krakow D, et al. Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse. Nat Genet 1998; 20: 157-162.
70. 70. Belin V, Cusin V, Viol G, et al. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet 1998; 19: 67-69.
71. 71. Shears DJ, Vassal HJ, Goodman FR, et al. Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat Genet 1998; 19: 70-73.